Mesenchymal stem cell-laden, personalized 3D scaffolds with controlled structure and fiber alignment promote diabetic wound healing
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The management of diabetic wounds remains a major therapeutic challenge in clinics. Herein, we report a personalized treatment using 3D scaffolds consisting of radially or vertically aligned nanofibers in combination with bone marrow mesenchymal stem cells (BMSCs). The 3D scaffolds have customizable sizes, depths, and shapes, enabling them to fit a variety of type 2 diabetic wounds. In addition, the 3D scaffolds are shape-recoverable in atmosphere and water following compression. The BMSCs-laden 3D scaffolds are capable of enhancing the formation of granulation tissue, promoting angiogenesis, and facilitating collagen deposition. Further, such scaffolds inhibit the formation of M1-type macrophages and the expression of pro-inflammatory cytokines IL-6 and TNF-α and promote the formation of M2-type macrophages and the expression of anti-inflammatory cytokines IL-4 and IL-10. Taken together, BMSCs-laden, 3D nanofiber scaffolds with controlled structure and alignment hold great promise for the treatment of diabetic wounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Human skin wounds: A major and snowballing threat to public health and the economy
Sen, C. K., Gordillo, G. M., Roy, S., Kirsner, R., Lambert, L., Hunt, T. K., Gottrup, F., Gurtner, G. C., & Longaker, M. T. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00543.x · Cited by 2,965
Chen, L., Tredget, E. E., Wu, P. Y. G., & Wu, Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001886 · Cited by 1,610 · cited 1×
“The advantages of BMSCs transplantation on skin wound healing are more widely appreciated [14, 42].”
BackgroundPlasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452
Mechanisms involved in the therapeutic properties of mesenchymal stem cells
da Silva Meirelles, L., Fontes, A. M., Covas, D. T., & Caplan, A. I. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.002 · Cited by 1,436
Harnessing nanotopography and integrin–matrix interactions to influence stem cell fate
Dalby, M. J., Gadegaard, N., & Oreffo, R. O. C. (2014) · Nature Materials · doi:10.1038/nmat3980 · Cited by 1,082 · cited 1×
“Nanotopographical features of substrate not only influence stem cell fate [26], but also retain stem-cell phenotype and maintain stem cell growth over eight weeks [27].”
BackgroundBrown, B. N., Londono, R., Tottey, S., Zhang, L., Kukla, K. A., Wolf, M. T., Daly, K. A., Reing, J. E., & Badylak, S. F. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.11.031 · Cited by 745
Ng, F., Boucher, S., Koh, S., Sastry, K. S. R., Chase, L., Lakshmipathy, U., Choong, C., Yang, Z., Vemuri, M. C., Rao, M. S., et al. (2008) · Blood · doi:10.1182/blood-2007-07-103697 · Cited by 580
Current challenges and opportunities in the prevention and management of diabetic foot ulcers.
Jeffcoate, W. J., Vileikyte, L., Boyko, E. J., Armstrong, D. G., & Boulton, A. J. M. (2018) · Diabetes Care · doi:10.2337/dc17-1836 · Cited by 475
Garg, K., Pullen, N. A., Oskeritzian, C. A., Ryan, J. J., & Bowlin, G. L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.065 · Cited by 457 · cited 1×
“Furthermore, nanofiber scaffolds with large pore size are able to increase expression of the M2 macrophages, along with decreased expression of the M1 macrophages [29, 30], suggesting nanofiber scaffolds with large pore size are capable of regulating the local inflammation to pro-regenerative status.”
BackgroundMirza, R. E., Fang, M. M., Weinheimer-Haus, E. M., Ennis, W. J., & Koh, T. J. (2014) · Diabetes · doi:10.2337/db13-0927 · Cited by 319 · cited 1×
“M1 type macrophages play a decisive role in the sustained pro-inflammatory response and lead to elevated levels of pro-inflammatory cytokines and proteases, ultimately reducing levels of various growth factors [57].”
BackgroundYao, C.-H., Yeh, J.-Y., Chen, Y.-S., Li, M.-H., & Huang, C.-H. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.1992 · Cited by 151
Cited by
Uhljar, L. É., & Ambrus, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020417 · Cited by 108
“Skin tissue scaffold Single-needle solution ES PCL DCM, DMF Poloxamer 407 BMSCs (C57BL/6 mice) [99]”
MethodYang, J., Huang, Z., Tan, J., Pan, J., Chen, S., & Wan, W. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.10.005 · Cited by 83
“Human skin tissue defects are primarily repaired by in situ growth of granulation tissue, which consists of infiltrating cells, neo-vascularization, and newly synthesized extracellular matrix [38,39].”
BackgroundSelf-citationNew dimensions of electrospun nanofiber material designs for biotechnological uses
Kamaraj, M., Moghimi, N., Chen, J., Morales, R., Chen, S., Khademhosseini, A., & John, J. V. (2024) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.11.008 · Cited by 44
Self-citationChe, H., Xu, J., Wu, D., Chen, S., Liu, C., Zhao, C., & Peng, K. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.11.002 · Cited by 19
Self-citation
Metadata
- Authors
- Chen, S., Wang, H., Su, Y., John, J. V., McCarthy, A., Wong, S. L., & Xie, J.
- Venue
- Acta Biomaterialia
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 108
- Pages
- 153-167
- ISSN
- 1742-7061 (ISSN-L)
- OpenAlex
- W3015039677
- Cited by
- 140
- References
- 11
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.